Why the study?
Brachial artery access for coronary diagnostic or therapeutic procedures carries a higher risk of vascular complications, prompting evaluation of whether a novel 3D-printed elbow joint fixation device reduces postoperative complications.
Does a novel 3D-printed elbow joint fixation device reduce postoperative complications in patients undergoing percutaneous coronary procedures via brachial access?
Does a novel 3D-printed elbow joint fixation device reduce postoperative complications in patients undergoing percutaneous coronary procedures via brachial access?
A novel 3D-printed elbow joint fixation device effectively reduces puncture site discomfort, swelling, and subcutaneous bleeding following brachial artery access for coronary procedures.
Answers are grounded in this paper and cite their sources.
Supports reduced discomfort and hemorrhage after brachial access; extends first RCT evidence for 3D-printed fixation devices.
Brachial artery access for coronary diagnostic or therapeutic procedures is associated with a greater risk of vascular complications. To determine whether 3D printing of a novel elbow joint fixation device could reduce postoperative complications after percutaneous coronary diagnostic or therapeutic procedures through the brachial artery. Patients who underwent percutaneous coronary diagnostic or therapeutic procedures by brachial access were randomly assigned to receive either a 3D-printed elbow joint fixation device (brace group) or traditional compression (control group) from March 2023 to December 2023. The severity of puncture site-related discomfort at 24 h postsurgery was significantly lower in the brace group ( P = 0.014). Similarly, the upper arm calibration rate at 24 h postsurgery was significantly lower in the brace group [0.024 (0.019–0.046) vs. 0.077 (0.038–0.103), P < 0.001], as was the forearm calibration rate [0.026 (0.024–0.049) vs. 0.050 (0.023–0.091), P = 0.007]. The brace group had a significantly lower area of subcutaneous hemorrhage at 24 h postsurgery [0.255 (0–1.00) vs. 1 (0.25–1.75) cm 2 ]. In patients who underwent percutaneous coronary diagnostic or therapeutic procedures by brachial access after manual compression hemostasis, the novel elbow joint fixation device was effective at reducing puncture site-related discomfort, alleviating the degree of swelling, and minimizing the subcutaneous bleeding area. Additionally, no significant complications were observed. Trial registration: China Clinical Trial Registration on 01/03/2023 (ChiCTR2300068791).
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: